WHO Virtual Consultation on the Safety of Adjuvanted Influenza Vaccines (3 June 2009)
A consultation was held by teleconference to review the safety of adjuvanted influenza vaccines. The purpose of this consultation was two-fold:
(1) To review known and theoretical safety concerns associated with using adjuvants in influenza vaccines
(2) To discuss ways to prospectively evaluate vaccine safety.
Participants in the teleconference included vaccine manufacturers, experts in adjuvant development, influenza vaccines and safety evaluation, as well as representatives from regulatory agencies, WHO and other stake-holders.